• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转醛醇酶通过调节谷胱甘肽-p38 信号抑制 CD36 表达,发挥对巨噬细胞泡沫细胞形成的保护作用。

Transaldolase inhibits CD36 expression by modulating glutathione-p38 signaling, exerting protective effects against macrophage foam cell formation.

机构信息

Department of Immunology, School of Medicine, Yangtze University, Jingzhou 434023, China.

Department of Oncology, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou 434023, China.

出版信息

Acta Biochim Biophys Sin (Shanghai). 2023 Aug 1;55(9):1496-1505. doi: 10.3724/abbs.2023146.

DOI:10.3724/abbs.2023146
PMID:37528662
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10520467/
Abstract

In atherosclerosis, macrophage-derived foam cell formation is considered to be a hallmark of the pathological process; this occurs via the uptake of modified lipoproteins. In the present study, we aim to determine the role of transaldolase in foam cell formation and atherogenesis and reveal the mechanisms underlying its role. Bone marrow-derived macrophages (BMDMs) isolated from mice successfully form foam cells after treatment with oxidized low-density lipoprotein (80 μg/mL). Elevated transaldolase levels in the foam cell model are assessed by quantitative polymerase chain reaction and western blot analysis. Transaldolase overexpression and knockdown in BMDMs are achieved via plasmid transfection and small interfering RNA technology, respectively. We find that transaldolase overexpression effectively attenuates, whereas transaldolase knockdown accelerates, macrophage-derived foam cell formation through the inhibition or activation of cholesterol uptake mediated by the scavenger receptor cluster of differentiation 36 (CD36) in a p38 mitogen-activated protein kinase (MAPK) signaling-dependent manner. Transaldolase-mediated glutathione (GSH) homeostasis is identified as the upstream regulator of p38 MAPK-mediated CD36-dependent cholesterol uptake in BMDMs. Transaldolase upregulates GSH production, thereby suppressing p38 activity and reducing the CD36 level, ultimately preventing foam cell formation and atherosclerosis. Thus, our findings indicate that the transaldolase-GSH-p38-CD36 axis may represent a promising therapeutic target for atherosclerosis.

摘要

在动脉粥样硬化中,巨噬细胞源性泡沫细胞的形成被认为是病理过程的标志;这是通过摄取修饰的脂蛋白发生的。在本研究中,我们旨在确定转醛醇酶在泡沫细胞形成和动脉粥样硬化发生中的作用,并揭示其作用的机制。从小鼠分离的骨髓来源的巨噬细胞(BMDMs)在用氧化的低密度脂蛋白(80μg/ml)处理后成功形成泡沫细胞。通过定量聚合酶链反应和western blot 分析评估泡沫细胞模型中转醛醇酶水平的升高。通过质粒转染和小干扰 RNA 技术分别实现 BMDMs 中转醛醇酶的过表达和敲低。我们发现,转醛醇酶过表达有效地减弱,而转醛醇酶敲低加速,通过 p38 丝裂原活化蛋白激酶(MAPK)信号依赖性方式,通过清道夫受体分化簇 36(CD36)介导的胆固醇摄取的抑制或激活,巨噬细胞源性泡沫细胞的形成。转醛醇酶介导的谷胱甘肽(GSH)动态平衡被确定为 BMDMs 中 p38 MAPK 依赖性 CD36 依赖性胆固醇摄取的上游调节剂。转醛醇酶上调 GSH 的产生,从而抑制 p38 活性并降低 CD36 水平,最终防止泡沫细胞形成和动脉粥样硬化。因此,我们的研究结果表明,转醛醇酶-GSH-p38-CD36 轴可能是动脉粥样硬化的一个有前途的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5a6/10520467/91cc235d11e9/ABBS-2023-085-t5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5a6/10520467/3d2606c29761/ABBS-2023-085-t1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5a6/10520467/9d7e1da2619c/ABBS-2023-085-t2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5a6/10520467/f5eb3333e290/ABBS-2023-085-t3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5a6/10520467/22ce092eb74b/ABBS-2023-085-t4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5a6/10520467/91cc235d11e9/ABBS-2023-085-t5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5a6/10520467/3d2606c29761/ABBS-2023-085-t1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5a6/10520467/9d7e1da2619c/ABBS-2023-085-t2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5a6/10520467/f5eb3333e290/ABBS-2023-085-t3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5a6/10520467/22ce092eb74b/ABBS-2023-085-t4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5a6/10520467/91cc235d11e9/ABBS-2023-085-t5.jpg

相似文献

1
Transaldolase inhibits CD36 expression by modulating glutathione-p38 signaling, exerting protective effects against macrophage foam cell formation.转醛醇酶通过调节谷胱甘肽-p38 信号抑制 CD36 表达,发挥对巨噬细胞泡沫细胞形成的保护作用。
Acta Biochim Biophys Sin (Shanghai). 2023 Aug 1;55(9):1496-1505. doi: 10.3724/abbs.2023146.
2
IL-34 promotes foam cell formation by enhancing CD36 expression through p38 MAPK pathway.IL-34 通过 p38 MAPK 通路促进 CD36 表达,从而促进泡沫细胞形成。
Sci Rep. 2018 Nov 26;8(1):17347. doi: 10.1038/s41598-018-35485-2.
3
Reduced beta2-glycoprotein I protects macrophages from ox-LDL-induced foam cell formation and cell apoptosis.β2-糖蛋白 I 减少可保护巨噬细胞免受 ox-LDL 诱导的泡沫细胞形成和细胞凋亡。
Lipids Health Dis. 2013 Nov 16;12:174. doi: 10.1186/1476-511X-12-174.
4
TREM2 promotes cholesterol uptake and foam cell formation in atherosclerosis.TREM2 促进动脉粥样硬化中的胆固醇摄取和泡沫细胞形成。
Cell Mol Life Sci. 2023 May 3;80(5):137. doi: 10.1007/s00018-023-04786-9.
5
Inhibition of Glutathione Production Induces Macrophage CD36 Expression and Enhances Cellular-oxidized Low Density Lipoprotein (oxLDL) Uptake.抑制谷胱甘肽生成可诱导巨噬细胞CD36表达并增强细胞对氧化型低密度脂蛋白(oxLDL)的摄取。
J Biol Chem. 2015 Sep 4;290(36):21788-99. doi: 10.1074/jbc.M115.654582. Epub 2015 Jul 17.
6
Impact of glutathione peroxidase-1 deficiency on macrophage foam cell formation and proliferation: implications for atherogenesis.谷胱甘肽过氧化物酶-1 缺乏对巨噬细胞泡沫细胞形成和增殖的影响:对动脉粥样硬化形成的意义。
PLoS One. 2013 Aug 22;8(8):e72063. doi: 10.1371/journal.pone.0072063. eCollection 2013.
7
Curcumin inhibits oxLDL-induced CD36 expression and foam cell formation through the inhibition of p38 MAPK phosphorylation.姜黄素通过抑制 p38MAPK 磷酸化抑制 oxLDL 诱导的 CD36 表达和泡沫细胞形成。
Food Chem Toxicol. 2013 Aug;58:77-85. doi: 10.1016/j.fct.2013.04.008. Epub 2013 Apr 16.
8
Vav protein guanine nucleotide exchange factor regulates CD36 protein-mediated macrophage foam cell formation via calcium and dynamin-dependent processes.Vav 蛋白鸟嘌呤核苷酸交换因子通过钙和依赖 dynamin 的过程调节 CD36 蛋白介导的巨噬细胞泡沫细胞形成。
J Biol Chem. 2011 Oct 14;286(41):36011-36019. doi: 10.1074/jbc.M111.265082. Epub 2011 Aug 24.
9
Intermedin inhibits macrophage foam-cell formation via tristetraprolin-mediated decay of CD36 mRNA.中介素通过三肽重复蛋白 32 介导的 CD36mRNA 降解抑制巨噬细胞泡沫细胞形成。
Cardiovasc Res. 2014 Feb 1;101(2):297-305. doi: 10.1093/cvr/cvt254. Epub 2013 Nov 18.
10
Nicotine potentiates proatherogenic effects of oxLDL by stimulating and upregulating macrophage CD36 signaling.尼古丁通过刺激和上调巨噬细胞 CD36 信号来增强 oxLDL 的促动脉粥样硬化作用。
Am J Physiol Heart Circ Physiol. 2013 Aug 15;305(4):H563-74. doi: 10.1152/ajpheart.00042.2013. Epub 2013 Jun 7.

引用本文的文献

1
Protective Effect of -Acetylcysteine (NAC) on oxLDL-Induced Endothelial Dysfunction.N-乙酰半胱氨酸(NAC)对氧化型低密度脂蛋白(oxLDL)诱导的内皮功能障碍的保护作用。
J Microbiol Biotechnol. 2025 Aug 5;35:e2504039. doi: 10.4014/jmb.2504.04039.
2
Targeting NADPH oxidase-driven oxidative stress in diabetic cardiomyopathy: mechanisms and therapeutic perspectives.靶向糖尿病心肌病中NADPH氧化酶驱动的氧化应激:机制与治疗前景
Front Pharmacol. 2025 Jul 3;16:1610429. doi: 10.3389/fphar.2025.1610429. eCollection 2025.
3
Macrophage CBX4 Potentiates Atherosclerosis by its SUMO E3 Ligase Activity.

本文引用的文献

1
Hepatocyte-specific TMEM16A deficiency alleviates hepatic ischemia/reperfusion injury via suppressing GPX4-mediated ferroptosis.肝特异性 TMEM16A 缺乏通过抑制 GPX4 介导的铁死亡缓解肝缺血/再灌注损伤。
Cell Death Dis. 2022 Dec 26;13(12):1072. doi: 10.1038/s41419-022-05518-w.
2
WWP2 ameliorates oxidative stress and inflammation in atherosclerotic mice through regulation of PDCD4/HO-1 pathway.WWP2 通过调控 PDCD4/HO-1 通路减轻动脉粥样硬化小鼠的氧化应激和炎症反应。
Acta Biochim Biophys Sin (Shanghai). 2022 Aug 25;54(8):1057-1067. doi: 10.3724/abbs.2022091.
3
Disruption of USP9X in macrophages promotes foam cell formation and atherosclerosis.
巨噬细胞CBX4通过其SUMO E3连接酶活性增强动脉粥样硬化。
Cardiovasc Drugs Ther. 2025 Jun 6. doi: 10.1007/s10557-025-07724-y.
4
3,3'-Diindolylmethane Ameliorates Metabolism Dysfunction-Associated Fatty Liver Disease via AhR/p38 MAPK Signaling.3,3'-二吲哚甲烷通过芳烃受体/ p38丝裂原活化蛋白激酶信号通路改善代谢功能障碍相关脂肪性肝病
Nutrients. 2025 May 15;17(10):1681. doi: 10.3390/nu17101681.
5
Ferroptosis: a potential target for the treatment of atherosclerosis.铁死亡:动脉粥样硬化治疗的潜在靶点。
Acta Biochim Biophys Sin (Shanghai). 2024 Mar 25;56(3):331-344. doi: 10.3724/abbs.2024016.
USP9X 在巨噬细胞中的缺失促进泡沫细胞形成和动脉粥样硬化。
J Clin Invest. 2022 May 16;132(10). doi: 10.1172/JCI154217.
4
The Integration of Metabolomic and Proteomic Analyses Revealed Alterations in Inflammatory-Related Protein Metabolites in Endothelial Progenitor Cells Subjected to Oscillatory Shear Stress.代谢组学和蛋白质组学分析的整合揭示了受到振荡剪切应力作用的内皮祖细胞中炎症相关蛋白质代谢物的变化。
Front Physiol. 2022 Feb 16;13:825966. doi: 10.3389/fphys.2022.825966. eCollection 2022.
5
Macrophage NFATc3 prevents foam cell formation and atherosclerosis: evidence and mechanisms.巨噬细胞 NFATc3 可防止泡沫细胞形成和动脉粥样硬化:证据和机制。
Eur Heart J. 2021 Dec 14;42(47):4847-4861. doi: 10.1093/eurheartj/ehab660.
6
The antioxidant N-acetylcysteine promotes immune response and inhibits epithelial-mesenchymal transition to alleviate pulmonary fibrosis in chronic obstructive pulmonary disease by suppressing the VWF/p38 MAPK axis.抗氧化剂 N-乙酰半胱氨酸通过抑制 VWF/p38 MAPK 轴促进免疫反应并抑制上皮-间充质转化,从而减轻慢性阻塞性肺疾病中的肺纤维化。
Mol Med. 2021 Sep 3;27(1):97. doi: 10.1186/s10020-021-00342-y.
7
SLC1A5 co-expression with TALDO1 associates with endocrine therapy failure in estrogen receptor-positive breast cancer.SLC1A5 与 TALDO1 的共表达与雌激素受体阳性乳腺癌内分泌治疗失败相关。
Breast Cancer Res Treat. 2021 Sep;189(2):317-331. doi: 10.1007/s10549-021-06298-1. Epub 2021 Jul 19.
8
TNFAIP3 Interacting Protein 3 Is an Activator of Hippo-YAP Signaling Protecting Against Hepatic Ischemia/Reperfusion Injury.肿瘤坏死因子-α 诱导蛋白 3 相互作用蛋白 3 是 Hippo-YAP 信号的激活剂,可防止肝缺血/再灌注损伤。
Hepatology. 2021 Oct;74(4):2133-2153. doi: 10.1002/hep.32015. Epub 2021 Aug 30.
9
High Transaldolase 1 expression predicts poor survival of patients with upper tract urothelial carcinoma.高转醛醇酶 1 表达预示着上尿路尿路上皮癌患者预后不良。
Pathol Int. 2021 Jul;71(7):463-470. doi: 10.1111/pin.13101. Epub 2021 Apr 13.
10
Hepatocyte TMEM16A Deletion Retards NAFLD Progression by Ameliorating Hepatic Glucose Metabolic Disorder.肝细胞中跨膜蛋白16A缺失通过改善肝脏葡萄糖代谢紊乱延缓非酒精性脂肪性肝病进展
Adv Sci (Weinh). 2020 Mar 20;7(10):1903657. doi: 10.1002/advs.201903657. eCollection 2020 May.